Matthias Balk
Overview
Explore the profile of Matthias Balk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allner M, Rak A, Balk M, Rupp R, Almajali O, Tamse H, et al.
Support Care Cancer
. 2025 Mar;
33(4):278.
PMID: 40080201
Background: Head and neck cancer (HNC) patients experience a variety of post-treatment symptoms that affect their quality of life (QoL). This study aims to assess the most prevalent symptoms and...
2.
Koch M, Balk M, Schlaffer S, Agaimy A, Iro H, Mueller S
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941715
The objective of this study was to compare results after endoscopic (ES) and open surgery (OpS) for esthesioneuroblastoma over a 40-year period. In a retrospective study, patients who had undergone...
3.
Gostian M, Allner M, Rak A, Balk M, Rupp R, Ostgathe C, et al.
Ear Nose Throat J
. 2024 Dec;
:1455613241276776.
PMID: 39651655
In this study, long-term survivors of head and neck cancer (HNC) were evaluated regarding their symptom burden and quality of life (QoL). This prospective study was performed during the regular...
4.
Stogbauer F, Wirth M, Lauterbach M, Wollenberg B, Schmidl B, Hoch C, et al.
Br J Cancer
. 2024 Nov;
132(2):212-221.
PMID: 39613843
Background: We aimed to validate the prognostic significance of tumor budding (TB) in p16-positive oropharyngeal squamous cell carcinomas (OPSCC). Methods: We analyzed digitized H&E-stained slides from a multicenter cohort of...
5.
Bauerschmitz L, Agaimy A, Eckstein M, Balk M, Iro H, Schleder S, et al.
Eur Arch Otorhinolaryngol
. 2024 Oct;
282(2):1111-1117.
PMID: 39404883
A 53 year old female presented with a six-year history of right-sided slow deterioration in hearing and a feeling of pressure in the right ear. The patient had not experienced...
6.
Jansen V, Gostian A, Allner M, Balk M, Rupp R, Iro H, et al.
Eur Arch Otorhinolaryngol
. 2024 Oct;
282(3):1427-1436.
PMID: 39361139
Purpose: To evaluate postoperative pain and discomfort after parotid surgery with regard to different surgical approaches. Methods: This clinical study was carried out at a single tertiary referral center (2021-2022)...
7.
Donaubauer A, Frey B, Weber M, Allner M, Vogl C, Almajali O, et al.
Front Oncol
. 2024 Sep;
14:1451035.
PMID: 39346733
The approval and effectiveness of immune checkpoint inhibitors in head-and-neck squamous cell carcinoma (HNSCC) highlights the role of the immune system in this tumor entity. HNSCCs not only interacts with...
8.
Balk M, Rak A, Rupp R, Sievert M, Muller S, Koch M, et al.
Ear Nose Throat J
. 2024 Sep;
:1455613241274025.
PMID: 39292947
Head and neck cancer (HNC) is a critical concern in oncology, with notable disparities in survival rates. While the long-term symptom burden in HNC survivors and its impact on quality...
9.
Schuster J, Wendler O, Pesold V, Koch M, Sievert M, Balk M, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893148
Background: The lack of screening methods for LSCC is a critical issue, as treatment options and the treatment outcome greatly depend on the stage of LSCC at initial diagnosis. Therefore,...
10.
Mantsopoulos K, Gehrking M, Thimsen V, Sievert M, Mueller S, Rupp R, et al.
Am J Otolaryngol
. 2024 Apr;
45(4):104260.
PMID: 38613928
Objective: The aim of the study was to trace the development of surgical therapy in a large cohort, examine its changes at one single institution that has been specializing in...